BioNovelus Shows Successful Trial Results for Crop Protection and Post-Harvest in Guatemala

CR-10 Biofungicide Helps Improve Crop Productivity and Sustainability.


Phoenix, July 24, 2017 (GLOBE NEWSWIRE) -- / FOR IMMEDIATE RELEASE  — Results from the field trials for BioNovelus (OTC Pink: ONOV) CR-10 Biofungicide for crop protection and post-harvest security and preservation have been very positive. These tests are ongoing in Guatemala as multiple harvests are monitored to gather data in order to show growers a decrease in the cost of production on a growing cycle as well as an increase in crop productivity. 

“These trials are done in the fields and follow the three to five month growing cycle of the fruits and vegetables being tested,” says Jean Ekobo, CEO and Founder of BioNovelus. “For example, it takes three months to get the first harvest of peppers. Then, the pepper plants can produce another three to five times over the season. With BioNovelus CR-10 Biofungicide used as a preventive measure, growers tell us they believe they can produce three additional harvests. That will help them increase crop productivity and, with it, sustainability.”

With regard to food security and food preservation, in testing CR-10 Biofungicide is showing impressive results in its ability to kill bacteria, fungi, and spores. It expands the shelf-life while keeping produce pathogen-free, fresh and crisp. “Food growers and packers have been happily surprised by the performance of CR-10,” Ekobo continues. “For the zucchinis, for example, by using multiple toxic chemicals they could preserve the vegetables for about 11 to 15 days. Using only environmentally-responsible CR-10, with no other added products, they monitored the zucchinis after 30 days and were impressed with the results.” 

Increasing the shelf-life of vegetables and fruits should allow food growers to reach more markets, serve more customers, and increase their bottom line. It can also increase sustainability and give access to fresher and safer food to people in remote places. CR-10 Biofungicide comes at the right time because, at the present rate of growth, we will need to feed two billion extra people by 2050.1

Testimonials of growers are posted on BioNovelus’ YouTube channel. Here are the following links: http://bit.ly/TomatoTrial, http://bit.ly/PepperTrial, http://bit.ly/ZucchiniTrial.

Source: 1. https://farmingfirst.org/sdg-toolkit#section_1

About BioNovelus:
BioNovelus is a bioscience company that honors the environment with innovative, cost effective, and disruptive technology-based solutions to crop protection, food security, and health challenges.

Forward-Looking Statements
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the fiscal year 2017 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.

Factors that could cause the Company’s results to differ materially from forward looking statements regarding the efficacy of the crop restoration and results of CR-10 include the lack of capital needed to complete testing, more rigorous testing of multiple fields of crops in multiple conditions, the lack of experience with pursuing approval of this product and modifications and receipt of information that may be demanded by the registration of the CR-10 formula and the delays in the various government approval processes unrelated to the product itself. Factors that could cause lower rates of success in CR-10 eradication of fungi and bacteria include the method and timing of applications of CR-10, the impact of the strength of fungi and bacteria contamination, and other environmental conditions resulting in re-infection. Factors that may impact Guatemalan acceptance of our product include the compatibility with other chemical products.

There is no assurance of when registrations in Guatemala will be obtained for CR-10 Biofungicide and various applications as several field trials are still in progress. There is no assurance that the coffee rust application or any other crop protection or post-harvest protection applications will prove commercially viable. There is no assurance that any transaction will be done with Guatemalan distributors.

Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, general business and economic conditions beyond the Company's control the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, compatibility with other chemical products, the application of the products, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements because of new information, since these statements may no longer be accurate or timely.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

— 30 —



            

Contact Data